Perkins, A. 2019. StatinWISE - A series of randomised controlled N-of-1 trials in patients who have discontinued or are considering discontinuing statin use due to muscle- related symptoms to assess if atorvastatin treatment causes more muscle symptoms than placebo. [Online]. London School of Hygiene & Tropical Medicine, London, United Kingdom. Available from: https://doi.org/10.17037/DATA.00001314.
Perkins, A. StatinWISE - A series of randomised controlled N-of-1 trials in patients who have discontinued or are considering discontinuing statin use due to muscle- related symptoms to assess if atorvastatin treatment causes more muscle symptoms than placebo [Internet]. London School of Hygiene & Tropical Medicine; 2019. Available from: https://doi.org/10.17037/DATA.00001314.
Perkins, A (2019). StatinWISE - A series of randomised controlled N-of-1 trials in patients who have discontinued or are considering discontinuing statin use due to muscle- related symptoms to assess if atorvastatin treatment causes more muscle symptoms than placebo. [Project]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00001314.
Description
Statins are the most commonly prescribed treatment in the UK. Recently updated NICE guidelines have lowered the threshold for statin use to include all patients with a 10% or greater 10-year risk of cardiovascular disease. Previous randomised trials have established the prevalence of serious adverse effects of statins such as rhabdomyolysis, however, many patients discontinue statins due to less severe symptoms, such as muscle pain or fatigue. Randomised trials have shown no differences between those taking statin and placebo in terms of the prevalence of these side effects (approximately 9%), but currently there is no pathway of care for clinicians to empirically and objectively evaluate whether symptoms reported by a statin-user are caused by the statin itself or the so-called ‘nocebo’ effect (symptoms reflecting patient expectation of side effects). Given the effectiveness of statins in preventing cardiovascular disease, accurate data on the cause of symptoms experienced during statin use are needed to reliably inform patient and clinician about continuation of use. The proposed StatinWISE trial will provide definitive answers to this important uncertainty about statin therapy.
Funder | National Institute for Health Research (NIHR) |
---|---|
Language(s) of written materials | English |
Data Creators | Perkins, A |
---|---|
Project contact | Perkins, Alexander |
Associated roles | Smeeth, L (Principal Investigator) and Shakur-Still, H (Co-Investigator) |
LSHTM Faculty/Department | Faculty of Epidemiology and Population Health |
Research Group | Clinical Trials Unit |
Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom |
Date Deposited | 07 Aug 2019 13:59 |
---|---|
Last Modified | 01 Mar 2024 09:44 |
Publisher | London School of Hygiene & Tropical Medicine |
Data collections in this project
Downloads
Data Management Plan
Filename: StatinWISE-Statistical-Analysis-Plan-1.0-060819.pdf
Description: StatinWISE Statistical Analysis Plan
Licence: Creative Commons: Attribution-Noncommercial 3.0
DownloadProject Plan
Filename: Protocol-and-appendices_v3.0_28-June-17.pdf
Description: StatinWISE Protocol and Appendices
Licence: Creative Commons: Attribution-Noncommercial 3.0
Download